European Healthcare Acquisition & Growth Company B.V.

Equities

EHCS

NL0015000K10

Investment Holding Companies

Market Closed - Euronext Amsterdam 11:11:01 2024-04-12 am EDT 5-day change 1st Jan Change
9.15 EUR 0.00% Intraday chart for European Healthcare Acquisition & Growth Company B.V. 0.00% -8.50%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
European Healthcare Acquisition & Growth Shareholders Back Extension of Business Combination Deadline MT
Tranche Update on European Healthcare Acquisition & Growth Company B.V.'s Equity Buyback Plan announced on October 4, 2023. CI
European Healthcare Acquisition & Growth Company B.V.'s Equity Buyback announced on October 4, 2023, has expired with 18,761,038 shares, representing 93.8% for ?190.8 million. CI
European Healthcare Acquisition & Growth Proposes Extension to Merger Completion Deadline MT
European Healthcare Acquisition & Growth Company B.V. announces an Equity Buyback. CI
European Healthcare Acquisition & Growth Company B.V. authorizes a Buyback Plan. CI
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
European Healthcare Acquisition & Growth to Propose Extension to Business Combination Deadline MT
European Healthcare Acquisition & Growth, Croma-Pharma Cancel Merger Talks MT
CROMA-PHARMA GmbH cancelled the acquisition of European Healthcare Acquisition & Growth Company B.V. in reverse merger transaction. CI
European Healthcare Acquisition & Growth Drops Croma-Pharma Merger from General Meeting Agenda MT
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
European Healthcare Acquisition & Growth Company B.V. Auditor Raises 'Going Concern' Doubt CI
European Healthcare Acquisition & Growth Company B.V. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
European Healthcare SPAC To Merge With Austrian Aesthetic Medicine-focused Croma-Pharma MT
CROMA-PHARMA GmbH agreed to acquire European Healthcare Acquisition & Growth Company B.V. in reverse merger transaction. CI
European Healthcare Acquisition & Growth Company B.V. Auditor Raises 'Going Concern' Doubt CI
European Healthcare Acquisition & Growth Company B.V. has completed an IPO in the amount of ?200 million. CI
European Healthcare Acquisition & Growth Company B.V. has filed an IPO in the amount of ?200 million. CI
Chart European Healthcare Acquisition & Growth Company B.V.
More charts
European Healthcare Acquisition & Growth Company B.V. is a Special Purpose Acquisition Company (SPAC) aimed at acquiring companies with principal operations in Europe in the healthcare sector, with a special focus on the subsectors Biotechnology and Specialty Pharma, Pharma Services, Medical Technology and Medical Devices, Diagnostic and Lab Services, Bioinformatics as well as Life Science Tools.
More about the company
  1. Stock Market
  2. Equities
  3. EHCS Stock
  4. News European Healthcare Acquisition & Growth Company B.V.
  5. European Healthcare Acquisition & Growth Proposes Extension to Merger Completion Deadline